Faris Alzahrani

Dr. Faris Alzahrani

Ministry of health, Abhā, ‘Asīr, Saudi Arabia
orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 August 2022 in Pathogens
Verified
Journal Article
Open access
PDF file
Najim Z. AlshahraniNajim Z. Alshahrani
Najim Z. Alshahrani
FAFaris Alzahrani
Faris Alzahrani
AAAbdullah Alarifi
Abdullah Alarifi
MAMohammed Ridha Algethami
Mohammed Ridha Algethami
MAMaathir Naser Alhumam
Maathir Naser Alhumam
Ranjit SahRanjit Sah
Ranjit Sah
Monkeypox is re-emerging and spreading over the world, posing a serious threat to human life, especially in non-endemic countries, including Saudi Arabia. Due to the paucity of research on knowledge about monkeypox in Saudi Arabia, this study aimed to evaluate the general population’s knowledge of monkeypox in a sample of the country. A web-based cross-sectional survey was conducted from 25 May 2022 to 15 July 2022. Participants’ knowledge about monkeypox on a 23-item scale and socio-demographic characteristics were gathered in the survey. Pearson’s Chi-square test was used to compare knowledge level (categorized into high and low) and explanatory variables. Out of 480, only 48% of the respondents had high knowledge (mean score > 14). Participants’ age, marital status, residential region, living in the urban area, education level, employment status, being a healthcare worker, income, and smoking status were significantly associated with the level of knowledge about monkeypox (p < 0.01). Overall, social media (75.0%) was the most frequently reported source from where participants obtained monkeypox-related information followed by TV and radio (45.6%), family or friend (15.6%), and healthcare provider (13.8%). We found that overall knowledge of monkeypox infection was slightly poor among the Saudi population. These findings highlight the urgent need for public education on monkeypox to promote awareness and engage the public ahead of the outbreak.

8 December 2022 in Vaccines
Verified
Journal Article
Open access
PDF file
Najim Z. AlshahraniNajim Z. Alshahrani
Najim Z. Alshahrani
MAMohammed Ridha Algethami
Mohammed Ridha Algethami
AAAbdullah Alarifi
Abdullah Alarifi
FAFaris Alzahrani
Faris Alzahrani
EAEman Alshehri
Eman Alshehri
Alfonso J. Rodriguez-MoralesAlfonso J. Rodriguez-Morales
Alfonso J. Rodriguez-Morales
The growing incidence of human monkeypox cases emphasizes the significance of prevention, early detection, and prompt responses for healthcare providers. The aim of this study was to assess the knowledge and attitudes toward monkeypox infection among physicians, a frontline healthcare worker group, in Saudi Arabia. A cross-sectional survey assessing knowledge and attitudes towards monkeypox infection on multiple-item scales was sent to physicians in Saudi Arabia. The associations between independent factors and either knowledge or attitude were assessed. The final analysis included 398 participants. Approximately 55% of the surveyed participants had a “good knowledge” score about human monkeypox. The adjusted logistic regression analysis showed that being a female physician, working in the private sector, and having information on human monkeypox during medical school or residency years were the only factors associated with a good level of knowledge about human monkeypox. However, physicians’ knowledge and attitudes regarding monkeypox infection are inadequate and influenced by various factors. There is a significant knowledge gap between the therapeutic management of monkeypox and its vaccination. Training and knowledge assessments are important, especially when studies show significant improvement in related and specific knowledge.

5 January 2022 in Psych Journal
Verified
Journal Article
Open access
PDF file
FAFaris Alzahrani
Faris Alzahrani
Najim Z. AlshahraniNajim Z. Alshahrani
Najim Z. Alshahrani
ASAbdulelah Abu Sabah
Abdulelah Abu Sabah
AZAbdulmajid Zarbah
Abdulmajid Zarbah
SSSaeed Abu Sabah
Saeed Abu Sabah
MMMohammed Mamun
Mohammed Mamun
This systematic review and meta‐analysis generates evidence of the prevalence and associated factors of common mental disorders (i.e., depression, anxiety, and stress) related to the pandemic among the Saudi general population. Following the Preferred Reporting Items for Systematic Reviews and Meta‐Analyses guidelines, a comprehensive literature search was performed in the respective databases (e.g., PubMed, Scopus, Web of Science), from 22 July to 17 August 2021, and identified a total of 220 articles. Adhering to the inclusion criteria (i.e., original research concerning the prevalence and/or associated factors of depression and/or anxiety and/or stress disorders among the general Saudi population, published in English peer‐reviewed journals), 15 studies were included in this review which consisted of a total of 262,656 participants. The overall prevalence of depression, anxiety, and stress was 30% (95% confidence interval [CI]: 22% to 38%, I2 = 99.58%), 20% (95% CI: 16% to 24%, I2 = 99.32%), and 29% (95% CI: 11% to 47%, I2 = 99.76%), respectively. Risk factors of mental health problems were found to be female sex, younger age group, single/divorced marital status, lower education, lower income, non‐Saudis, unemployment status, students, being in a small family and living with elderly of the sociodemographic factors. Smokers, less physical activities, lower resilience, reduced immune status, chronic health problems, and psychiatric illness history were associated with a higher degree of mental health problems. In addition, coronavirus disease 2019 (COVID‐19)‐related risk factors of mental illness included lack of knowledge, fear, worry and concern, family member or friends’ infection or death, lockdown restrictions, quarantine, confirmed or suspected of COVID‐19 infection, and even pandemic effects. In conclusion, appropriate mental health preventive approaches for the Saudi general people are highly needed, where this review can be worthy of help by providing in detailed information to the respective authorities.

21 July 2022 in Medicina
Verified
Journal Article
Open access
PDF file
Najim Z. AlshahraniNajim Z. Alshahrani
Najim Z. Alshahrani
AAAbdullah Alsabaani
Abdullah Alsabaani
IRIman Ridda
Iman Ridda
Harunor RashidHarunor Rashid
Harunor Rashid
FAFaris Alzahrani
Faris Alzahrani
AAAbdulelah Saleh Saeed Albeshri
Abdulelah Saleh Saeed Albeshri
Backgroundand objectives: Although several vaccines have been produced and administered around the world, new SARS-CoV-2 worsened the COVID-19 infection risk and impacted the initial vaccine dosage effectiveness. Based on studies indicating that the third and fourth COVID-19 vaccine doses significantly reduced COVID-19 transmission, Saudi Arabia has been administering COVID-19 booster vaccine doses to its citizens. The purpose of this study was to evaluate the uptake of the COVID-19 vaccine booster in relation to the socio-demographic characteristics and other associated factors among the Saudi population. Materials and Methods: This study was an online analytical cross-sectional study using a self-administered questionnaire. Pearson Chi-square test and multiple logistic regression analyses were used to determine factors associated with the uptake of COVID-19 booster dose vaccines. Results: A total of 2332 responded to our study. Overall, 527 (22.6%) participants had received a booster dose. An age of 55 and above (aOR: 5.415; 95% CI: 2.719–10.783), Eastern region (aOR: 2.513; 95% CI: 1.566–4.033), history of influenza vaccination at annual intervals (aOR: 2.387; 95% CI: 1.730–3.293), the first dose of Moderna vaccine (aOR: 1.324; 95% CI: 1.160–1.510), and cancer (aOR: 2.161; 95% CI: 1.218–3.879) were independent factors most associated with a higher uptake of the COVID-19 vaccine booster dose. In contrast, the second dose of Moderna vaccine (aOR: 0.794; 95% CI: 0.683–0.922), AstraZeneca vaccine (aOR: 0.691; 95% CI: 0.509–0.939), strong symptoms from side effects after the second dose of the COVID-19 vaccine (aOR: 0.615; 95% CI: 0.404–0.935) were independent factors most associated with a lower uptake of the COVID-19 vaccine booster dose. Conclusions: Our findings indicate low COVID-19 vaccine booster uptake. This necessitates the need for strategies to address discouraging factors of the COVID-19 vaccine booster dose uptake and engage the Saudi population to raise awareness about the importance of the booster dose.

17 May 2019 in International Journal of Rheumatic Diseases
Verified
Journal Article
Closed access
PDF file
FAFaris Alzahrani
Faris Alzahrani
BABashayer Alsultan
Bashayer Alsultan
HAHana Alahmari
Hana Alahmari
AAAli Almannaa
Ali Almannaa
MAMalak Asseri
Malak Asseri
AAAbdullah Alsabaani
Abdullah Alsabaani

4 January 2023 in Sustainability
Verified
Journal Article
Open access
PDF file
Najim Z. AlshahraniNajim Z. Alshahrani
Najim Z. Alshahrani
IRIman Ridda
Iman Ridda
Harunor RashidHarunor Rashid
Harunor Rashid
FAFaris Alzahrani
Faris Alzahrani
LOLujain Mohammed Bin Othman
Lujain Mohammed Bin Othman
HAHassan Ali Alzaydani
Hassan Ali Alzaydani
Background: COVID-19 vaccine booster dose hesitancy amongst the Saudi Arabia population is a concern. The objectives of the study were to explore the Saudi public’s willingness to receive a COVID-19 vaccine booster dose and identify the factors affecting their willingness. Methods: From December 2021 to March 2022, an online cross-sectional survey using an anonymous, structured, and self-administered questionnaire was conducted among members of the Saudi public aged ≥18 years who did not receive a COVID-19 vaccine booster dose. Results: Of the 2101 respondents, 86.8% expressed a willingness to receive a COVID-19 vaccine booster dose. Multiple logistic regression analysis showed that age (18 to 25 years) (adjusted odds ratio [aOR] = 2.54; 95% confidence interval [95% CI] = 1.14–5.74), being single (aOR = 2.85; 95% Cl = 1.42–5.72), and prior receipt of an influenza vaccine (aOR = 2.45; 95% Cl = 1.80–3.34) were significantly associated with participants’ willingness to receive the COVID-19 vaccine booster dose. Having a bachelor’s degree or above (aOR = 0.95; 95% CI = 0.81–0.99) and not following COVID-19 news (aOR = 0.70; 95% CI = 0.52–0.89) were associated with a significant likelihood of having no intention to receive the COVID-19 vaccine boosters. Conclusions: Most Saudi people were willing to have the COVID-19 vaccine booster dose, with age and prior influenza vaccination as the predictors; paradoxically, a university-level qualification was a barrier.